Nadine M.

Nadine M. is an accomplished professional with extensive experience in corporate finance and business development within the life sciences and healthcare sectors. Currently serving as the Managing Director of Corporate Finance for Life Sciences and Healthcare at Van Lanschot Kempen since January 2022, Nadine previously held the position of Executive Director at Kempen & Co from February 2018 to January 2022. Nadine's background includes roles at Allergan, where responsibilities spanned international business development across multiple regions, and several key positions at Aptalis, focusing on licensing and business development initiatives. Prior experience encompasses significant roles at Eurand Pharmaceutical Technologies and Eli Lilly, showcasing a solid track record in licensing, business strategy, and market analysis. Nadine holds a degree from Université St. Joseph, obtained between 1992 and 1997.